Stryker Corp header image

Stryker Corp

SYK

Equity

ISIN US8636671013 / Valor 974330

New York Stock Exchange, Inc (2024-09-18)
USD 361.36-0.71%

Stryker Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Stryker Corp is a prominent player in the medical technology industry, focusing on providing innovative products and services in areas such as MedSurg, Neurotechnology, Orthopaedics, and Spine. The company collaborates with healthcare professionals to enhance patient outcomes and overall healthcare quality. With a global presence, Stryker is dedicated to driving advancements in medical technologies to ultimately improve the quality of healthcare worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Increase

Stryker Corp's net sales for the second quarter of 2024 reached $5,422 million, reflecting a significant increase from the $4,996 million reported in the same quarter of 2023. This growth underscores the company's strong market presence and successful sales strategies.

Gross Profit Growth

In the second quarter of 2024, Stryker Corp reported a gross profit of $3,416 million, up from $3,181 million in the second quarter of 2023. This improvement in gross profit highlights the company's effective cost management and operational efficiency.

Net Earnings Rise

Stryker Corp's net earnings for the second quarter of 2024 were $825 million, compared to $738 million in the same period of 2023. This increase in net earnings demonstrates the company's ability to enhance profitability through strategic initiatives and robust performance.

Earnings Per Share

For the second quarter of 2024, Stryker Corp reported basic earnings per share of $2.17 and diluted earnings per share of $2.14. This is an improvement from the basic earnings per share of $1.95 and diluted earnings per share of $1.93 reported in the second quarter of 2023, indicating strong shareholder value creation.

Dividend Declaration

Stryker Corp declared a cash dividend of $0.80 per share of common stock for the second quarter of 2024, up from $0.75 per share in the second quarter of 2023. This increase in dividends reflects the company's commitment to returning value to its shareholders.

Summarized from source with an LLMView Source

Key figures

23.2%1Y
32.4%3Y
63.9%5Y

Performance

21.2%1Y
25.6%3Y
30.9%5Y

Volatility

Market cap

137705 M

Market cap (USD)

Daily traded volume (Shares)

288,133

Daily traded volume (Shares)

1 day high/low

365.81 / 359.87

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.70%USD 8.02
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.38%USD 2.14
Genetic Technologies Ltd
Genetic Technologies Ltd Genetic Technologies Ltd Valor: 1124821
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
35.71%EUR 0.019
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.27%EUR 31.10
Shionogi Seiyaku KK
Shionogi Seiyaku KK Shionogi Seiyaku KK Valor: 763280
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%JPY 6,303.00
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 417.50
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%CHF 122.40
COLTENE HOLDING AG
COLTENE HOLDING AG COLTENE HOLDING AG Valor: 2534325
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%CHF 47.60
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 236.11
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70